BTLA/CD272 Rekombinanter Antikörper

BTLA/CD272 Rekombinant Antikörper für FC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

FC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

241318H5

Kat-Nr. : 98096-1-PBS

Synonyme

BTLA, 241318H5, B and T lymphocyte attenuator, B and T lymphocyte associated, B- and T-lymphocyte attenuator



Geprüfte Anwendungen

Produktinformation

98096-1-PBS bindet in FC, Indirect ELISA BTLA/CD272 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen Rekombinantes Protein
Vollständiger Name B and T lymphocyte associated
Berechnetes Molekulargewicht 289 aa, 33 kDa
GenBank-ZugangsnummerBC107091
Gene symbol BTLA
Gene ID (NCBI) 151888
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C.

Hintergrundinformationen

BTLA ( B and T lymphocyte attenuator), also known as CD272, is a member of the CD28 superfamily and is a type I membrane glycoprotein identified as an inhibitory receptor (PMID: 33859648). BTLA is extensively expressed in lymph nodes, thymus, and spleen, with little or no expression in organs such as the heart, kidney, brain, and liver (PMID: 33859648). Among immune cells, BTLA is primarily expressed in B and T cells, with higher expression in B cells compared to T cells in the mouse spleen (PMID: 33859648). BTLA plays a crucial role in regulating stimulatory and inhibitory signals in immune responses.